Evidence map›Paper›PMID 30094934›Full record

ArticleJournal of cellular and molecular medicine2018

Association between high-sensitivity C-reactive protein, lipoprotein-associated phospholipase A2 and carotid atherosclerosis: A cross-sectional study.

Huamin Liu, Yan Yao, Youxin Wang, Long Ji, Kai Zhu, Haitao Hu, Jianxin Chen, Jichun Yang, Qinghua Cui, Bin Geng and 3 more

Open access · goldAbstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 41 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 3 countries.

Huamin LiuSchool of Public Health, Taishan Medical University, Tai'an, China.ORCID 0000-0002-2762-8012
Yan YaoDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Youxin WangBeijing Key Laboratory of Clinical Epidemiology, School of Public Health, Capital Medical University, Beijing, China.
Long JiSchool of Public Health, Taishan Medical University, Tai'an, China.
Kai ZhuSchool of Public Health, Taishan Medical University, Tai'an, China.
Haitao HuDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas.
Jianxin ChenBeijing University of Chinese Medicine, Beijing, China.
Jichun YangDepartment of Physiology and Pathophysiology, School of Basic Medical Sciences Key Laboratory of Molecular Cardiovascular Science of the Ministry of Education Center for Non-coding RNA Medicine, Peking University Health Science Center, Beijing, China.ORCID 0000-0001-8150-2923
Qinghua CuiDepartment of Biomedical Informatics, School of Basic Medical Sciences, Key Laboratory of Molecular Cardiovascular Science of the Ministry of Education, Center for Non-coding RNA Medicine, Peking University Health Science Center, Beijing, China.
Bin GengHypertension Center, Fuwai Hospital, State Key Laboratory of Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Qing LiuThe Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China.
Dong LiSchool of Public Health, Taishan Medical University, Tai'an, China.
Yong ZhouBeijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Taishan Medical University · CNCapital Medical University · CNPeking University · CNBeijing University of Chinese Medicine · CNCentral South University · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNThe University of Texas Medical Branch at Galveston · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High-sensitivity C-reactive protein (hs-CRP) and lipoprotein-associated phospholipase A2 (Lp-PLA2) have been reported to be independent predictors of atherosclerosis. However, whether the combination of these two markers can improve the prediction of atherosclerosis is unknown. This study aimed to evaluate the association between combining hs-CRP and Lp-PLA2 and predicting carotid atherosclerosis. A total of 1982 participants aged ≥40 years were included in this study. Hs-CRP and Lp-PLA2 were measured by a high-sensitivity nephelometry assay and quantitative sandwich enzyme-linked immunosorbent assay, respectively. Ultrasonography was performed on the bilateral carotid arteries to evaluate stenosis and plaques. Multivariable logistic regression models were used to analyse the association between the combination of the hs-CRP and Lp-PLA2 levels and carotid plaques and stenosis. A total of 1579 (79.7%) and 181 (9.1%) subjects had carotid plaques and carotid stenosis, respectively. The group with high hs-CRP and Lp-PLA2 levels had the highest prevalence of carotid plaques (90.6%) and stenosis (20.8%). A significant association was found between high hs-CRP and Lp-PLA2 levels and carotid stenosis (adjusted odds ratio [OR]: 2.39; 95% confidence interval [CI]: 1.13-5.09), but this combination was not associated with carotid plaques (OR: 2.62, 95% CI: 0.93-7.38). The results suggested that the combination of hs-CRP and Lp-PLA2 were better predictors than either protein alone with regard to carotid atherosclerosis.

Indexed as

Genetic Predisposition to Disease1-Alkyl-2-acetylglycerophosphocholine EsteraseAdultAgedBiomarkersCarotid Artery DiseasesC-Reactive ProteinCross-Sectional StudiesFemaleGenetic Association StudiesGenotypeHumansLogistic ModelsMaleMiddle AgedPolymorphism, Single Nucleotide1-Alkyl-2-acetylglycerophosphocholine EsteraseBiomarkersC-Reactive ProteinPLA2G7 protein, humancarotid atherosclerosiscombinationhigh-sensitivity C-reactive proteinlipoprotein-associated phospholipase A2

Identifiers

PMID30094934
PMCPMC6156242
OpenAlexW2887196980

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.